Paper27445495
Analgesic effectiveness and tolerability of oral oxycodone/naloxone and pregabalin in patients with lung cancer and neuropathic pain: an observational analysis.
De Santis S and 6 others. Onco Targets Ther, 2016. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Analgesic effectiveness and tolerability of oral oxycodone/naloxone and pregabalin in patients with lung cancer and neuropathic pain: an observational analysis. Papers, record 27445495. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27445495
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Analgesic effectiveness and tolerability of oral oxycodone/naloxone and pregabalin in patients with lung cancer and neuropathic pain: an observational analysis.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11755892 | Incidence, prevalence, and management of opioid bowel dysfunction. | Am J Surg | 2001 | https://conductscience.org/library/papers/11755892 | PubMed |
| 2 | 21249653 | Laxatives or methylnaltrexone for the management of constipation in palliative care patients. | Cochrane Database Syst Rev | 2011 | https://conductscience.org/library/papers/21249653 | PubMed |
| 3 | 11068116 | Defining the clinically important difference in pain outcome measures. | Pain | 2000 | https://conductscience.org/library/papers/11068116 | PubMed |
| 4 | 21937568 | A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain. | Palliat Med | 2012 | https://conductscience.org/library/papers/21937568 | PubMed |
| 5 | 23680581 | Opioid withdrawal syndrome after treatment with low-dose extended-release oxycodone and naloxone in a gastric cancer patient with portal vein thrombosis. | J Pain Symptom Manage | 2013 | https://conductscience.org/library/papers/23680581 | PubMed |
| 6 | 26644526 | Randomized Trial of Low-Dose Morphine Versus Weak Opioids in Moderate Cancer Pain. | J Clin Oncol | 2016 | https://conductscience.org/library/papers/26644526 | PubMed |
| 7 | 23748119 | Interventional management of neuropathic pain: NeuPSIG recommendations. | Pain | 2013 | https://conductscience.org/library/papers/23748119 | PubMed |
| 8 | 21401835 | Bowel function during pain therapy with oxycodone/naloxone prolonged-release tablets in patients with advanced cancer. | Int J Clin Pract | 2011 | https://conductscience.org/library/papers/21401835 | PubMed |
| 9 | 22312101 | American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. | J Clin Oncol | 2012 | https://conductscience.org/library/papers/22312101 | PubMed |
| 10 | 21343919 | Opioid-induced constipation: challenges and therapeutic opportunities. | Am J Gastroenterol | 2011 | https://conductscience.org/library/papers/21343919 | PubMed |
| 11 | 24249829 | Efficacy and gastrointestinal tolerability of oral oxycodone/naloxone combination for chronic pain in outpatients with cancer: an observational study. | Am J Hosp Palliat Care | 2014 | https://conductscience.org/library/papers/24249829 | PubMed |
| 12 | 22313329 | Quality of life benefits and cost impact of prolonged release oxycodone/naloxone versus prolonged release oxycodone in patients with moderate-to-severe non-malignant pain and opioid-induced constipation: a UK cost-utility analysis. | J Med Econ | 2012 | https://conductscience.org/library/papers/22313329 | PubMed |
| 13 | 23577077 | Randomised phase II trial (NCT00637975) evaluating activity and toxicity of two different escalating strategies for pregabalin and oxycodone combination therapy for neuropathic pain in cancer patients. | PLoS One | 2013 | https://conductscience.org/library/papers/23577077 | PubMed |
| 14 | 25575709 | Informed drug choices for neuropathic pain. | Lancet Neurol | 2015 | https://conductscience.org/library/papers/25575709 | PubMed |
| 15 | 21576968 | Long-term controlled-release oxycodone and pregabalin in the treatment of non-cancer pain: an observational study. | Eur Neurol | 2011 | https://conductscience.org/library/papers/21576968 | PubMed |
| 16 | 20851519 | NeuPSIG guidelines on neuropathic pain assessment. | Pain | 2011 | https://conductscience.org/library/papers/20851519 | PubMed |
| 17 | 21865137 | Post hoc analysis of pregabalin vs. non-pregabalin treatment in patients with cancer-related neuropathic pain: better pain relief, sleep and physical health. | Clin Transl Oncol | 2011 | https://conductscience.org/library/papers/21865137 | PubMed |
| 18 | 22300860 | Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. | Lancet Oncol | 2012 | https://conductscience.org/library/papers/22300860 | PubMed |
| 19 | 19244085 | Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. | Ann Oncol | 2009 | https://conductscience.org/library/papers/19244085 | PubMed |
| 20 | 23215628 | Combined oral prolonged-release oxycodone and naloxone in chronic pain management. | Expert Opin Investig Drugs | 2013 | https://conductscience.org/library/papers/23215628 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38793067 | Managing Severe Cancer Pain with Oxycodone/Naloxone Treatment: A Literature Review Update. | J Pers Med | 2024 | https://conductscience.org/library/papers/38793067 | PubMed |
| 37679047 | Hydrocodone, Oxycodone, and Morphine Metabolism and Drug-Drug Interactions. | J Pharmacol Exp Ther | 2023 | https://conductscience.org/library/papers/37679047 | PubMed |
| 35117656 | Neurological paraneoplastic syndrome caused by small cell lung cancer: a case report. | Transl Cancer Res | 2020 | https://conductscience.org/library/papers/35117656 | PubMed |
| 34441829 | Combination Therapy for Neuropathic Pain: A Review of Recent Evidence. | J Clin Med | 2021 | https://conductscience.org/library/papers/34441829 | PubMed |
| 33642876 | Oxycodone/Acetaminophen: The Tailoring Combination Treatment for Specific Clinical Profile of Opioid Well-Responsive Cancer Pain. | Cancer Manag Res | 2021 | https://conductscience.org/library/papers/33642876 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TENM1 | 10178 | PubTator's text mining | https://conductscience.org/library/genes/10178 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/27445495
GET https://conductscience.org/api/papers/v1/27445495/references?page=2